Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|September 18, 2025
Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancerGalina Semenova, Sander Frank, Ruth Dumpit, et al.
Asian Journal of Urology|December 22, 2017
Mismatch repair enzyme expression in primary and castrate resistant prostate cancerBelinda Nghiem, Xiaotun Zhang, Hung-Ming Lam, et al.
The Prostate|February 13, 2023
Clinical, pathologic, and molecular features of amphicrine prostate cancerLaura S Graham, Michael C Haffner, Erolcan Sayar, et al.
Molecular Cancer Research : MCR|May 4, 2017
Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155Michael D Nyquist, Alexandra Corella, John Burns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Transforming Growth Factor-{beta}-Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor InhibitionCynthia C T Sprenger, Kathleen Haugk, Shihua Sun, et al.
JAMA Oncology|June 4, 2021
Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNAMichael T Schweizer, Smruthy Sivakumar, Hanna Tukachinsky, et al.
Cancer Cell|October 22, 2011
Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1Changmeng Cai, Housheng Hansen He, Sen Chen, et al.
Plos One|October 8, 2013
A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumorsXiaoyu Qu, Grace Randhawa, Cynthia Friedman, et al.
Neoplasia (New York, N.Y.)|November 3, 2009
HE3235 inhibits growth of castration-resistant prostate cancerTheodore D Koreckij, Richard J Trauger, Robert Bruce Montgomery, et al.
Molecular Cancer Research : MCR|March 16, 2013
PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortalityEric G Bluemn, Elysia Sophie Spencer, Brigham Mecham, et al.
Pageof 10